Cargando…
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
BACKGROUND: The role of radiolabeled choline (Cho) in patients with biochemical recurrence after radical treatment for prostate cancer (PCa) is well established. Its widespread clinical use has prompted the depiction of incidentalomas, unusual sites of metastatic lesions, as well as false positive a...
Autores principales: | Sollini, Martina, Pasqualetti, Francesco, Perri, Marzio, Coraggio, Gabriele, Castellucci, Paolo, Roncali, Massimo, Boni, Roberto, Lazzeri, Elena, Galeandro, Maria, Paiar, Fabiola, Versari, Annibale, Erba, Paola Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006359/ https://www.ncbi.nlm.nih.gov/pubmed/27581366 http://dx.doi.org/10.1186/s40644-016-0085-1 |
Ejemplares similares
-
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
por: Pasqualetti, Francesco, et al.
Publicado: (2016) -
[(18)F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer
por: Sollini, Martina, et al.
Publicado: (2021) -
[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019) -
PET and PET/CT with (68)Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
por: Sollini, Martina, et al.
Publicado: (2014) -
(18)F-FDG and (68)Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study
por: Taralli, Silvia, et al.
Publicado: (2018)